Associate Professor Justin Denholm

Medical Director, Victorian Tuberculosis Program at Melbourne Health; Principal Research Fellow, Department of Microbiology and Immunology, University of Melbourne; The Peter Doherty Institute for Infection and Immunity

See research profile

Health & Medicine

Q&A

Q&A: Dexamethasone and COVID-19

According to a trial in the UK, dexamethasone is “the first drug shown to improve survival in COVID-19” patients. But what is it and what do these results tell us?

Health & Medicine

From decades to days: 3D modelling tuberculosis

3D modelling of the mutations in TB means doctors around the world could soon tailor individual treatments for the disease in a matter of days, rather than years

Health & Medicine

Tuberculosis: Still a major killer

Researchers for first time show the significant burden of tuberculosis on adolescents and young adults, a group often ignored in disease control efforts